Berjame, Angelita R.

HRN: 17-64-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/29/2023
11/06/2023
IV
600
Q8
Infected Breast Mass
Waiting Final Action 
10/29/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/29/2023
11/06/2023
IV
1.5
Q8
Infected Breast Mass
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: